Apollomics, Inc. Doses First Patient in Phase I Clinical Trial of APL-102
Foster City, CA, Hangzhou and […]
Apollomics, Inc. Doses First Patient in A Phase I Clinical Trial of APL-102
Foster City, CA, Hangzhou and […]